Publications
5491 Results
- Journal / Conference
- Pharmacogenetics and Genomics Dec 1;31(9):215-220
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34149004
- PMC
- PMC8490297
Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/Leucovorin or Epirubicin/Cisplatin/Fluorouracil Before and After Chemoradiation on CALGB (Alliance) 80101
- Journal / Conference
- Breast Cancer Research and Treatment Jul;188(2):477-487
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID33852121
- PMC
- PMC8262517
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology, Aug 10;39(23):2539-2551; Jun 6;JCO2100976. doi: 10.1200/JCO.21.00976. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID34092112
- Study Number(s)
- CTSU/EA1131
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131
- Journal / Conference
- Contemporary Clinical Trials Oct;109:106519
- Year
- 2021
- Research Committee(s)
- Prevention and Epidemiology
- PMID
- PMID34333138
- PMC
- PMC8665835
- Study Number(s)
- S0820
Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial
- Journal / Conference
- Cancer, Dec 15;127(24):4574-4584
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID34351619
- PMC
- PMC8665001
Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years
- Journal / Conference
- Journal of Clinical Oncology, Oct 1;39(28):3171-3181
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID34357781
- PMC
- PMC8478386
- Study Number(s)
- CTSU/E2112
E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN Cancer Research Group
- Journal / Conference
- JAMA Network Open, Jul 1;4(7):e2118433. doi: 10.1001/jamanetworkopen.2021.18433
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID34323986
- PMC
- PMC8323000
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic
- Journal / Conference
- Journal of Clinical Oncology, Oct 15;127(20):3801-3808
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34374082
- PMC
- PMC8478698
- Study Number(s)
- CTSU/C80405
Racial Differences in Survival and Response to Therapy in Patients with Metastatic Colorectal Cancer: A Secondary Analysis of CALGB/SWOG 80405 (Alliance A151931)
- Journal / Conference
- Journal for Immunotherapy of Cancer, Aug;9(8):e002990. doi: 10.1136/jitc-2021-002990
- Year
- 2021
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID34380663
- PMC
- PMC8330584
- Study Number(s)
- S1609
A Multicenter Phase II Trial (SWOG S1609, Cohort 51) of Ipilimumab and Nivolumab in Metastatic or Unresectable Angiosarcoma: a Sub-Study of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART)
- Journal / Conference
- Leukemia Jul 28. doi: 10.1038/s41375-021-01323-0. Online ahead of print.
- Year
- 2021
- Research Committee(s)
- Leukemia
- PMID
- PMID34316017
- Study Number(s)
- CTSU/C10603